Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Market Cap ($1.21 Billion)
Market Cap & Net Worth: Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016)
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. market cap. Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (SHG:605016) has a market capitalization of $1.21 Billion (CN¥8.27 Billion) as of November 9, 2026. Listed on the SHG stock exchange, this China-based company holds position #7833 globally and #1724 in its home market, demonstrating a 12.07% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s stock price CN¥19.68 by its total outstanding shares 420012320 (420.01 Million). Also see Shandong Bailong Chuangyuan Bio-Tech Co. operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Market Cap History (2021–2026)
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. market cap history from 2021 to 2026. Data shows growth from $1.08 Billion to $1.21 Billion (11.95% CAGR). Check 605016 stock price for real-time trading data and today's change.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 605016 net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.96x
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s market cap is 0.96 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.60x
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s market cap is 3.60 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.08 Billion | $653.36 Million | $104.48 Million | 1.65x | 10.32x |
| 2022 | $933.94 Million | $721.89 Million | $150.75 Million | 1.29x | 6.20x |
| 2023 | $1.72 Billion | $868.26 Million | $193.00 Million | 1.99x | 8.93x |
| 2024 | $1.04 Billion | $1.15 Billion | $245.60 Million | 0.90x | 4.23x |
| 2025 | $1.33 Billion | $1.38 Billion | $368.55 Million | 0.96x | 3.60x |
Competitor Companies of 605016 by Market Capitalization
Companies near Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. in the global market cap rankings as of November 9, 2026. Also see Shandong Bailong Chuangyuan Bio-Tech Co. (605016) total assets for a full breakdown of the balance sheet.
Key companies related to Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. by market ranking:
- Nestlé S.A (F:NESM): Ranked #87 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #101 globally with a market cap of $199.45 Billion USD ( CHF157.76 Billion CHF).
- Danone SA (PA:BN): Ranked #529 globally with a market cap of $50.53 Billion USD ( €43.22 Billion EUR).
- Danone SA (F:BSND): Ranked #668 globally with a market cap of $39.61 Billion USD ( €33.88 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Nestlé S.A | F:NESM | $224.33 Billion | €93.40 |
| #101 | Nestle S.A. | SW:NESN | $199.45 Billion | CHF85.85 |
| #529 | Danone SA | PA:BN | $50.53 Billion | €67.12 |
| #668 | Danone SA | F:BSND | $39.61 Billion | €13.20 |
Market Capitalization of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2021–2026)
Market capitalization of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2021 to today. Between 2021 and today, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s market cap moved from $1.08 Billion to $ 1.21 Billion, with a yearly change of 11.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.21 Billion | -8.89% |
| 2025 | CN¥1.33 Billion | +27.81% |
| 2024 | CN¥1.04 Billion | -39.74% |
| 2023 | CN¥1.72 Billion | +84.55% |
| 2022 | CN¥933.94 Million | -13.40% |
| 2021 | CN¥1.08 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 9th, 2026 the market cap of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.21 Billion USD |
| MoneyControl | $1.21 Billion USD |
| MarketWatch | $1.21 Billion USD |
| marketcap.company | $1.21 Billion USD |
| Reuters | $1.21 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltit… Read more